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To characterize trends in incidence, prevalence, and health care outcomes in the idiopathic
intracranial hypertension (IIH) population in Wales using routinely collected health care data.
Methods
We used and validated primary and secondary care IIH diagnosis codes within the Secure
Anonymised Information Linkage databank to ascertain IIH cases and controls in a retro-
spective cohort study between 2003 and 2017. We recorded body mass index (BMI), depri-
vation quintile, CSF diversion surgery, and unscheduled hospital admissions in case and control
cohorts.
Results
We analyzed 35 million patient-years of data. There were 1,765 cases of IIH in 2017 (85%
female). The prevalence and incidence of IIH in 2017 was 76/100,000 and 7.8/100,000/y, a
significant increase from 2003 (corresponding figures = 12/100,000 and 2.3/100,000/y) (p <
0.001). IIH prevalence is associated with increasing BMI and increasing deprivation. The odds
ratio for developing IIH in the least deprived quintile compared to the most deprived quintile,
adjusted for sex and BMI, was 0.65 (95% confidence interval 0.55 to 0.76). Nine percent of IIH
cases had CSF shunts with less than 0.2% having bariatric surgery. Unscheduled hospital ad-
missions were higher in the IIH cohort compared to controls (rate ratio 5.28, p < 0.001) and in
individuals with IIH andCSF shunts compared to those without shunts (rate ratio 2.02, p < 0.01).
Conclusions
IIH incidence and prevalence is increasing considerably, corresponding to population increases
in BMI, and is associated with increased deprivation. This has important implications for health
care professionals and policy makers given the comorbidities, complications, and increased
health care utilization associated with IIH.
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Idiopathic intracranial hypertension (IIH) is a condition of
unknown etiology that is strongly associated with obesity. IIH
predominantly affects women of childbearing age and causes
chronic disabling headaches, visual disturbance, and, in a
minority of patients, permanent visual loss. The definitive
management is weight loss but a minority of patients require
surgery in order to preserve vision.1,2 People with IIH po-
tentially have high rates of health care utilization due to their
comorbidities, multiple specialist consultations, diagnostic
tests, CSF diversion procedures, and complications related to
CSF diversion surgery.
Given the increasing global burden of obesity and the strong
association of IIH with obesity, it would seem plausible to
assume that the incidence of IIH, as well as associated health
care utilization, is increasing.3,4 Although there is some evi-
dence to support this,1,4 overall there is a paucity of data
regarding the epidemiology, health care utilization, and out-
comes of people with IIH. To our knowledge, there have not
been any large population-level studies of IIH in Wales.
In this retrospective cohort study, we aimed to determine the
temporal trends of IIH incidence and prevalence in Wales and
health care utilization associated with IIH. We also investigated
the effects of socioeconomic deprivation and obesity on IIH
epidemiology.
Methods
This was a retrospective cohort study using anonymized,
routinely collected Welsh health care data within the Secure
Anonymised Information Linkage databank (SAIL) at
Swansea University, Wales, United Kingdom.5–7 SAIL con-
tains anonymized linked datasets from a range ofWelsh health
sources including hospital admission and demographic data
for the complete Welsh population (3.1 million, 2017 pop-
ulation estimate) and primary care records for approximately
80% of the Welsh population. SAIL uses an established and
validated split-file approach for anonymized data linkage.5,6
In the United Kingdom, primary care consists primarily of
general practitioners (GPs). Patients with IIH can first pre-
sent to their GP, optometry, neurology, or emergency de-
partment before being given a diagnosis by ophthalmologists
or neurologists in secondary care.
To validate the accuracy of IIH diagnosis codes in routinely
collected data, we anonymously linked a list of successive
definite and probable IIH cases in 2016 and 2017 from
Morriston Hospital Swansea (the regional neurosciences
center) with SAIL data. The IIH cases were reviewed by cli-
nicians and classed as definite if they met all IIH criteria or
probable if they met the criteria but a record of fundoscopy at
the time of diagnosis could not be found (table e-1, zenodo.
org/record/4064064).8 We reviewed all patients admitted to
Morriston Hospital in 2017 with an IIH ICD-10 diagnosis
code in their hospital admission record and checked whether
they had also been given a diagnosis of IIH by a consultant
neurologist.
To identify patients with IIH throughout Wales, we selected
patients who had been given primary care or secondary care IIH
diagnosis codes (table e-2, zenodo.org/record/4064064) within
the study window (January 1, 2003, to December 31, 2017).
We excluded likely cases of secondary intracranial hypertension
(CNS malignancies, venous sinus thrombosis, and malignant
hypertension) (table e-3, zenodo.org/record/4064064). We
also excluded patients with less than 1 year of primary care data
prior to diagnosis, with insufficient demographic data, and who
were diagnosed on their death date (figure e-1, zenodo.org/
record/4064064). We recorded bariatric surgery procedures
and CSF diversion and revision procedures within the IIH co-
hort (see tables e-4, e-5, and e-6 for codes, zenodo.org/record/
4064064). We calculated incidence and prevalence for every
year within the study window and also calculated incidence and
prevalence for each of the 7 health boards within Wales.
We recorded deprivation using the Welsh Index of Multiple
Deprivation (WIMD), 2011 version, in which Wales is di-
vided into 1,897 lower layer super output areas (LSOAs)
containing an average of 1,600 people.9 Weighted scores from
8 domains, representing different types of deprivation, are
aggregated to form a WIMD score for each LSOA. The fol-
lowing are the 8 domains that provide the weighted scores:
income, employment, health, education, access to services,
housing, community safety, and physical environment. Each
LSOA in Wales has been ranked from most deprived to least
deprived according to its WIMD score and then grouped into
quintiles, with quintile 1 being the most deprived and quintile
5 being the least deprived.
We created a control cohort for the case (IIH) cohort by 3:1
matching on sex, age (week of birth), and WIMD quintile at
time of diagnosis of IIH. For any analysis of the control cohort
involving diagnosis date, the control was given the diagnosis
date of the matched patient with IIH.
Glossary
BMI = body mass index; CI = confidence interval; GP = general practitioner; ICD-10 = International Classification of
Diseases–10; IGRP = Information Governance Review Panel; IIH = idiopathic intracranial hypertension; LSOA = lower super
output area; NSW = National Survey for Wales; SAIL = Secure Anonymised Information Linkage; WIMD = Welsh Index of
Multiple Deprivation.
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To measure obesity within the IIH and control cohorts, we
used primary care body mass index (BMI) data measured
during routine GP consultations. BMI is defined as body mass
in kilograms divided by height in meters squared. Within the
IIH cohort, most had at least 1 recorded BMI. For those with
more than 1 recorded BMI, we used the BMI nearest to the
diagnosis date. We excluded likely erroneous BMI values of
less than 10 kgm−2 and greater than 70 kgm−2.
We used BMI data recorded in primary care (GP) and self-
reported BMI data from the National Survey for Wales
(NSW) to measure temporal trends in obesity. The NSW is
completed on behalf of the Welsh Government and over
11,000 randomly selected individuals annually report on a
range of health- and lifestyle-related issues.10 Both sources of
BMI data are open to ascertainment bias. People with low or
high BMI are more likely to have their BMI recorded by their
GP and questionnaire respondents are likely to underestimate
their weight. We therefore also used a mean of both GP and
NSW BMI data to estimate temporal trends in obesity (BMI
>30 kg/m2) rates in the Welsh population.
We recorded the rate of unscheduled hospital admissions in
the IIH and control cohort. Unscheduled hospital admissions
were defined as emergency department attendances or
emergency/unscheduled hospital admissions (Patient Epi-
sode Dataset for Wales dataset).
Statistical Methods
We calculated IIH prevalence by dividing the number of
people with a diagnosis of IIH by the total number of people,
with sufficient demographic data, registered with a GP within
SAIL on July 1 each year. We calculated annual IIH incidence
rates by dividing the number of new IIH diagnosis by the
number of patient-years at risk in that time period.
We used a logistic regression model to compare the relative
contributions of BMI and deprivation on the risk of de-
veloping a new diagnosis of IIH. In this model, we included
every person with a primary care BMI measurement within
the study period. A diagnosis of IIH within the study period
was the binary outcome variable. For controls with multiple
BMImeasurements, we used the last recorded BMI before the
end of the study period. For individuals with IIH, we used the
BMI and deprivation quintile closest to diagnosis. We ex-
cluded any person who died during the study window.
We used a paired t test to compare changes in BMI mea-
surements for individuals, proportion tests to compare pro-
portions, and rate ratio tests to compare rates of hospital
admission. We used R version 3.5.3 for statistical analysis.
Standard Protocol Approvals, Registrations,
and Patient Consents
All studies using SAIL data need independent Information
Governance Review Panel (IGRP) approval. This study
obtained IGRP approval (ref 0695). This study used
anonymized, routinely collected data and therefore written in-
formed consent was not required. The Research Ethics Service
has previously confirmed that SAIL projects using anonymized,
routinely collected data do not require specific UK National
Health Service research ethics committee approval.
Data Availability
The detailed anonymized patient data used in this study are
potentially re-identifiable and therefore not directly available
for sharing but are available within the SAIL Databank at
Swansea University. All proposals to use SAIL data are subject
to review by an IGRP. Before any data can be accessed, ap-
proval must be given by the IGRP. The IGRP gives careful
consideration to each project to ensure proper and appro-
priate use of SAIL data. When access has been approved, it is
gained through a privacy-protecting safe haven and remote
access system referred to as the SAIL Gateway. SAIL has
established an application process to be followed by anyone
who would like to access data via SAIL (saildatabank.com/
application-process).
Results
We analyzed a total of 35 million patient-years of data (a mean
of 2.3 million patient-years of data per year) during the study
period (2003–2017).
Validating Diagnosis Codes
We identified 153 successive individuals with an IIH diagnosis
admitted to our neuroscience center in 2016 and 2017 (see
Methods). In order to validate the accuracy of IIH diagnosis
codes used in the routinely collected data, we anonymously
linked these 153 individuals with IIH diagnoses (138 definite
and 15 probable) to health care data within SAIL. A total of
149 of these cases had linked primary and secondary care data;
all 153 had linked secondary care data. We were able to as-
certain 125 out of our 149 individuals with definite or prob-
able IIH using GP codes alone (sensitivity 84%), 130/153
(sensitivity 85%) using hospital codes alone, and 140/153
using a combination of GP and hospital codes (sensitivity
92%). A total of 141 out of all 153 individuals having a hospital
ICD-10 code for IIH admitted to a neuroscience center in
2017 had a consultant neurologist diagnosis of IIH (specificity
87%; table e-7, zenodo.org/record/4064064). We used a
combination of GP and hospital codes to ascertain cases with
IIH for the remainder of the study.
IIH Prevalence, IIH Incidence, and
Obesity Trends
There were 2,275 people with primary or secondary care IIH
diagnosis codes within the study window. After excluding
potential secondary causes of intracranial hypertension and
cases with no demographic data or no preceding primary care
data, there was a prevalent IIH cohort of 1,765 in 2017 (figure
e-1, zenodo.org/record/4064064; and table 1). A total of 86%
of the cohort had a GP BMI recording at or after diagnosis of
IIH (figure 1).
Neurology.org/N Neurology | Volume 96, Number 8 | February 23, 2021 e1253
The prevalence of IIH increased greatly from 12/100,000 in
2003 to 76/100,000 in 2017 (p < 0.001) (figure 2A). The
incidence of IIH increased greatly from 2.3/100,000/y in
2003 to 7.8/100,000/y in 2017 (p < 0.001) (figure 2B). The
proportion of obese individuals (BMI >30 kg/m2) in Wales,
as measured using primary care data, increased significantly,
with 29% of the population being obese in 2003 compared to
40% in 2017 (p < 0.001). There were also significant increases
in obesity as measured by questionnaire data (figure 2C). IIH
incidence and prevalence by Welsh health boards is shown in
figure 3 and table e-8 (zenodo.org/record/4064064).
Association Among IIH, Deprivation, and BMI
Figure 4 illustrates the association between both IIH preva-
lence and incidence with obesity and the association between
obesity and deprivation. Figure 4, A–D, use incidence and
prevalence averaged over the whole study period and figure
4E uses obesity data for 2015 only. Similar patterns are seen
for all years in the study period (figures e-2, e-3, and e-4;
zenodo.org/record/4064064).
For both men and women, IIH prevalence and incidence are
strongly associatedwithBMI. For obesewomen (BMI>30kg/m2),
the mean prevalence and incidence of IIH was 180/100,000 and
23.5/100,000/y. The corresponding figures for women with an
ideal BMI (20 kg/m2 < BMI < 25 kg/m2) were 13.2/100,000 and
1.6/100,000/y, respectively. For obese men, the mean prevalence
and incidence of IIH was 21.2/100,000 and 2.6/100,000/y. The
corresponding figures formenwith an ideal BMI were 7.6/100,000
and 1.6/100,000/y, respectively. In 2015, 35.9% of people in the
most deprived quintile were obese, compared to 24.4% in the least
deprived quintile.
Table 2 shows odds ratios for developing IIH based on sex,
BMI, and deprivation score.
Table 1 Characteristics of the Study Cohort, n (%)
All Male Female
No. of cases 1,765 (100) 272 (15.4) 1,493 (84.6)
Age at diagnosis, y
<18 270 (15.3) 88 (32.6) 182 (12.2)
18–30 743 (42.1) 49 (18.0) 694 (46.5)
30–40 390 (22.1) 35 (12.9) 355 (23.8)
40–50 188 (10.7) 31 (11.4) 157 (10.5)
50–60 93 (5.3) 28 (10.3) 65 (4.4)
60+ 81 (4.6) 41 (15.1) 40 (2.7)




1,522 (86) 183 (67.3) 1,339 (89.7)
<25 164 (10.8) 33 (18.0) 131 (9.8)
25–30 284 (18.7) 66 (36.1) 218 (16.3)
>30 1,074 (70.6) 84 (46.0) 990 (74.0)
Mean (SD) 35.2 (8.5) 31.5 (8.4) 35.7(8.4)
WIMD deprivation quintile
1 (most deprived) 520 (29.5) 68 (25.0) 452 (30.3)
2 409 (23.2) 66 (24.3) 343 (23.0)
3 341 (19.3) 62 (22.8) 279 (18.7)
4 262 (14.8) 40 (14.7) 222 (14.9)
5 (least deprived) 233 (13.2) 36 (13.2) 197 (13.2)
Mean (SD) 2.59 (1.39) 2.67 (1.34) 2.58 (1.39)
Acetazolamide prescribed 965 (54.7) 89 (32.7) 876 (58.7)
CSF shunts Control cohort
Number of cases 158 (9.0) 5,295 (100)
Age at diagnosis, y
<18 23 (14.6) 810 (15.3)
18–30 70 (44.3) 2,229 (42.1)
30–40 43 (27.2) 1,170 (22.1)
40–50 16 (10.1) 564 (10.7)
50–60 6 (3.8) (>50)a 279 (5.3)
60+ 243 (4.6)
Age, y, mean (SD) 27.6(11.6) 30.1 (14.2)
BMI, kg/m2
Number with BMI recorded 140 (88.6) 4,251 (80.3)
<25 10 (7.1) 2015 (47.4)
25–30 21 (15.0) 1,196 (28.1)
>30 109 (77.9) 1,040 (24.5)
Table 1 Characteristics of the Study Cohort, n (%) (continued)
CSF shunts Control cohort
Mean (SD) 35.7 (7.3) 26.6 (6.5)
WIMD deprivation quintile
1 (most deprived) 54 (34.2) 1,560 (29.5)
2 42 (26.6) 1,227 (23.2)
3 32 (20.3) 1,023 (19.3)
4 16 (10.1) 786 (14.8)
5 (least deprived) 14 (8.9) 699 (13.2)
Mean (SD) 2.33 (1.28) 2.59 (1.39)
Acetazolamide prescribed 116 (73.4) 6 (0.1)
Abbreviations: BMI = body mass index; WIMD = Welsh Index of Multiple
Deprivation.
a Because of small numbers of patients with CSF shunts in the 50–60 and 60+
age groups, we have reported these together as patients with CSF shunts
>50 years old.
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Outcome Data
Thirteen patients with IIH (0.78%) were recorded as being
blind a mean of 858 days (28 months) after diagnosis. A total
of 32 patients (1.9%) were recorded as having at least mod-
erate visual impairment a mean of 804 days (26 months) after
diagnosis. A total of 158 patients (9%) underwent CSF di-
version procedures a mean of 491 days (16 months) after
diagnosis (see table 1 for the characteristics of the shunt co-
hort and figure e-5 [zenodo.org/record/4064064] for a
Kaplan-Meier plot). A total of 70 (44%) patients who had
CSF diversion procedures went on to have at least 1 revision
surgery.
A total of 691 patients with IIH had at least 2 BMI readings
after their diagnosis (first BMI was within 1 year of diagnosis
and the latest BMI reading was a mean of 5.1 years later).
These patients’ BMI increased by 0.48 kg/m2 (p = 0.02, 95%
confidence interval [CI] 0.07 to 0.89). Fewer than 6 optic
nerve fenestration procedures or gastric banding procedures
were performed (note that due to SAIL anonymization
guidance we cannot report groups of fewer than 6 individuals
or events).
Health Care Utilization
During the study period, the IIH cohort had 4,818 un-
scheduled hospital visits over 3,262,942 days (mean rate of
0.54/patient/year), considerably more than the 2,755 un-
scheduled hospital visits over 9,860,456 days in the control
cohort (mean rate of 0.10/patient/year; rate ratio 5.28; 95%
CI 5.04 to 5.54; p < 0.001). This amounts to 777 additional
unscheduled hospital visits for the cohort of 1,765 patients
with IIH when compared to controls (figure 5).
Patients with IIH who had CSF diversion surgery (n = 158)
had 1,215 unscheduled hospital visits over 407,751 days
(mean rate of 1.088 visits/patient/year). When compared to
patients with IIH without CSF shunts, the rate ratio for un-
scheduled hospital visits was 2.02 (95% CI 1.89 to 2.15; p <
0.01) (figure 5).
Discussion
We used a combination of primary and secondary care di-
agnosis codes in anonymized, routinely collected data to as-
certain cases of IIH in this large, retrospective cohort study.
Uniquely, we were able to validate our IIH case ascertainment
method and found a sensitivity of 92% when identifying a
linked set of confirmed IIH cases. Diagnostic codes used in
the United Kingdom are considered to be accurate,11 but
specific validation of UK primary and secondary IIH diagnosis
codes, which we have performed here, is rare. It would seem
reasonable to use similar methods in future epidemiologic
studies.
We found a significant increase in IIH incidence and preva-
lence in Wales. The prevalence of IIH in Wales increased
sixfold from 12/100,000 in 2003 to 76/100,000 in 2017 and
the incidence of IIH increased threefold from 2.3/100,000/y
in 2003 to 7.8/100,000/y in 2017. There were corresponding
increases in obesity rates, using primary care BMI measure-
ments, with 29% of the population being obese in 2003
compared to 40% in 2017.
Until recently, there has been a paucity of large-scale epide-
miologic studies of IIH. Older studies have found the in-
cidence of IIH to be 1–2/100,000.12–14 A recent meta-analysis
of 15 studies, from 10 different countries, included 889 patients
with IIH and found a pooled incidence of 1.2/100,000/y.15
Larger, more recent studies have found higher, and increasing,
incidence rates of IIH, in line with our findings. A study using
routinely collected English secondary care data identified
23,182 new cases of IIH (82.4% female) with an incidence of
2.3/100,000/y in 2002 and 4.7/100,000/y in 2016.1 Another
recent study used English primary care data to study cardio-
vascular risk inwomenwith IIH and found that the incidence of
IIH in women increased from 2.5 in 2005 to 9.3/100,000/y in
2017.16 A Minnesota study also demonstrated over a 24-year
period that IIH incidence was increasing in a highly correlated
fashion with obesity.4
The considerable increase in IIH incidence is multifactorial
but likely predominately due to rising obesity rates. The
worldwide prevalence of obesity nearly tripled between 1975
and 2016 and therefore these results also have global
relevance.17,18 The increase in IIH incidence may also be
attributable to increased IIH diagnosis rates due to raised
awareness of the condition and greater use of digital fundu-
scopy at routine optometry appointments. Misdiagnosis of
IIH may also contribute to increasing IIH incidence; for
Figure 1 Body Mass Index (BMI) at Diagnosis for the Idio-
pathic Intracranial Hypertension (IIH) Cohort
The distribution of BMI measurements at nearest IIH diagnosis for women
(ochre) and men (blue). The y-axis shows the proportion of either all female
or all male cases.
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example, there can be issues when interpreting fundoscopy in
patients with headache.19
We found a strong association between increasing BMI, sex
(female), and IIH. Around 85% of our IIH cohort was female,
similar to other studies.1,19We also found a significant association
with increased deprivation and IIH, particularly in women. A total
of 52.6% of our IIH cohort came from the 2 most deprived
quintiles, a very similar finding to a recent English study that had
52.3% of its cases from the 2 most deprived quintiles.1
The association between IIH and deprivation can be
explained by increasing obesity rates in more deprived areas.
However, results from our logistic regression model suggest
that even when adjusting for BMI, there was still an associa-
tion between IIH and deprivation in women, but not men.
This result was also seen in a recent study of English women
with IIH.5 We found that women were 1.5 times more likely
to develop IIH in the most deprived compared to the least
deprived areas, even after adjusting for BMI. In women it
therefore seems likely that factors that are associated with
Figure 2 Prevalence and Incidence of Idiopathic Intracranial Hypertension (IIH) Compared With Obesity (2003–2017)
Changes in (A) IIH prevalence and (B) IIH incidence with time during the study period. Ochre lines represent the female population, blue lines represent the
male population, and green lines represent the combined population. (C) Changes in the proportion of the population who are obese (body mass index >30
kg/m2) from general practitioner (GP) BMI measurements (red line), National Survey for Wales (NSW) data (green line), and a mean average of the two (blue
line) during the study period. The x-axis in all graphs represents time in years. Note NSW data were not available for 2003–2005 or 2015–2017.
e1256 Neurology | Volume 96, Number 8 | February 23, 2021 Neurology.org/N
deprivation, apart from obesity alone, also contribute to the
etiology of IIH. Central adiposity is prominent in IIH and it
may be that the distribution of fat changes with deprivation.20
Factors associated with deprivation such as diet, pollution,
smoking, and psychosocial stress may have a metabolic or en-
docrine effect by, for example, increasing circulating androgen
levels, which are associated with IIH and altered CSF flow.21
We found that for men, although our numbers were smaller,
IIH is associated with BMI only and not deprivation. There
was a weaker association of BMI with IIH and a smaller in-
crease in IIH incidence with time inmen when compared with
women. Men are 4 times less likely to develop IIH than
women after adjusting for BMI and deprivation. This adds to
the evidence that IIH in men has different characteristics than
IIH in women.1
We have demonstrated that people with IIH have increased
rates of unscheduled health care utilization compared with a
matched control cohort. The rate ratio for unscheduled
hospital admissions in the IIH cohort compared to the con-
trols was 5.28 (95% CI 5.04 to 5.54). A considerable pro-
portion of this excess in unscheduled hospital admissions
occurs at the time of diagnosis and can be explained by the
need for urgent investigation of papilledema with brain im-
aging and spinal fluid analysis. However, there is also a con-
siderable excess in unscheduled hospital admissions up to 2
years after diagnosis.
Figure 3 Choropleths Comparing Welsh Idiopathic Intracranial Hypertension (IIH) Incidence and Prevalence With
Deprivation
(A) Map of the current Welsh health boards. Choropleth maps show the distribution of (B) deprivation, measured as a percentage of the health board
population in the 2 most deprived Welsh Index of Multiple Deprivation (WIMD) quintiles (1–2); (C) IIH incidence 2015–2017 by the health board; and (D) IIH
prevalence in 2017 by the health board. Data for the PowysHealth board could not be presented for incidence and prevalence due to restrictions in obtaining
small numbers from Secure Anonymised Information Linkage. See also table e-8 (zenodo.org/record/4064064). NHS = National Health Service.
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It is likely that these admissions are for severe headache. In the
past, emergency admissions may have led to therapeutic
lumbar punctures, although recent UK consensus guidelines
advise against therapeutic lumbar punctures in the majority of
cases.22 There is therefore some scope to reduce emergency
admissions through better management of headache, patient
education, and rapid access to outpatient specialist advice.
Interestingly, the rate of unscheduled admissions is higher in
Figure 4 Relationship of Idiopathic Intracranial Hypertension (IIH) Prevalence and IncidenceWith Obesity and Deprivation
Association between IIH prevalence (A) and incidence (B) with body mass index (BMI). BMI <20 kg/m2 is defined as underweight, 20 kg/m2 < BMI < 25 kg/m2
normalweight, 25 kg/m2 <BMI < 30 kg/m2overweight, andBMI >30 kg/m2 as obese. (C, D) Relationship between IIH prevalence and incidencewith deprivation
as measured by the Welsh Index of Multiple Deprivation (1 = most deprived, 5 = least deprived). (E) Relationship between obesity and deprivation for 2015
(similar relationships exist for other study years; see figure e-2, zenodo.org/record/4064064). The green line is obtained from primary care BMI measure-
ments, the blue line from Welsh Health Survey BMI data, and the red line is the mean of the 2 measurements. GP = general practitioner; NSW = National
Survey for Wales.
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the IIH cohort in the 3 years leading up to diagnosis, sug-
gesting an opportunity for earlier diagnosis and earlier
intervention.
About 9% of people with IIH in Wales receive CSF diversion
procedures a mean of 1.33 years after diagnosis. Individuals
with IIH who have undergone CSF diversion procedures also
have significantly increased unscheduled health care admis-
sion rates compared with individuals with IIH who have not
undergone CSF diversion procedures (rate ratio for un-
scheduled admissions 2.02, 95% CI 1.89 to 2.15). They have
around a 40% chance of having at least 1 CSF shunt revision
procedure.
Forty percent of our IIH cohort had a second BMI recording
after diagnosis. In these 691 individuals, their mean BMI in-
creased by 0.48 kgm−2 (p = 0.02, 95% CI 0.07 to 0.89). This
corresponds to an increase of 1.3 kg (using an average height
of 1.62 meters for women in Wales). This reflects the diffi-
culty in body weight reduction despite weight loss being the
main management strategy for IIH.2 Despite this, there were
very low rates of bariatric surgery in our cohort. Although 9%
had shunts, less than 0.3% had bariatric surgery to tackle the
underlying obesity. Moreover, the shunt population still had
high rates of hospital attendance despite invasive treatment.
We analyzed a large number (32 million patient-years) of
population-level data, integrating both primary and secondary
care datasets and obtaining a large cohort of IIH cases and
matched controls. Using routinely collected data reduces re-
cruitment bias seen in other studies. We also include routinely
collected BMI measurements for the majority of our IIH cohort
in addition to deprivation measures in our regression model.
This was a retrospective study. Routinely collected health care
data are not primarily collected for research purposes, can be
incomplete, and may contain inaccurate diagnosis codes. At
the time of analysis, within SAIL we had access to 100% of the
Table 2 Odds Ratios (ORs) (95% Confidence Intervals
[CIs]) for Developing Idiopathic Intracranial
Hypertension by Sex, Deprivation, and Body
Mass Index (BMI) Based on a Logistic Regression
Model
Model OR (95% CI) p Value
Sex
Male 1 (reference)
Female 3.96 (3.51–4.50) <0.00001a
Deprivation quintile
1 (most deprived) 1 (reference)
2 0.88 (0.76–1.01) 0.068
3 0.79 (0.68–0.91)a 0.0015a
4 0.73 (0.62–0.86)a 0.0001a
5 (least deprived) 0.65 (0.55–0.76)a <0.00001a
BMI 1.13 (1.13–1.14)a <0.00001a
Male
Deprivation quintile
1 (most deprived) 1 (reference)
2 1.29 (0.86–1.94) 0.23
3 0.97 (0.62–1.51) 0.90
4 0.74 (0.45–1.21) 0.24
5 (least deprived) 0.76 (0.46–1.22) 0.26
BMI 1.10 (1.08–1.12)a <0.00001a
Female
Deprivation quintile
1 (most deprived) 1 (reference)
2 0.84 (0.72–0.97)a 0.019a
3 0.77 (0.65–0.90)a 0.001a
4 0.73 (0.61–0.86)a 0.0003a
5 (least deprived) 0.65 (0.54–0.77)a <0.00001a
BMI 1.13 (1.13–1.14)a <0.00001a
Deprivation is measured using the Welsh Index of Multiple Deprivation
(WIMD) with 1 being the most deprived quintile and 5 being the least de-
prived quintile (see methods for more details). Results are displayed for 3
models: 1) male and female; 2) male only 3) female only. All individuals in
Wales with available BMI measurements during the study period were in-
cluded (1,522 with IIH and 1,655,014 without).
a p Value <0.05.
Figure 5 Rates of Unscheduled Hospital Visits Among 3
Cohorts
Rates of unscheduled hospital visits (per person per year) versus time since
idiopathic intracranial hypertension (IIH) diagnosis in months. A negative
value indicates time before the diagnosis and a positive value indicates time
after the diagnosis. Green line represents the IIH cohort; red line represents
the control cohort (matched on age, sex, and deprivation quintile); blue line
represents the IIH cohort with CSF diversion surgery (CSF shunts).
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Welsh population’s secondary care diagnosis codes but only
80% of the population’s primary care data. BMI is not rou-
tinely measured by GPs, raising the possibility of ascertain-
ment bias as those who have BMI recorded are more likely to
have ongoing weight issues. We made an attempt to adjust for
this by also looking at national questionnaire data for BMI,
but these self-reported data are subject to underreporting of
obesity. We used an area-based measure of deprivation
(WIMD), which, like other commonly used deprivation
markers, does not take into account individual levels of dep-
rivation. We did not specifically record prescriptions of drugs
such as tetracyclines and retinoids that can cause secondary
intracranial hypertension although this probably accounts for
a small number of cases.23
IIH incidence and prevalence in Wales are increasing con-
siderably, corresponding to population increases in BMI. IIH
is associated with increasing deprivation in women even after
adjusting for obesity, suggesting additional etiologic factors
associated with deprivation apart from BMI. This effect was
not seen in men, pointing to sex-specific drivers for IIH.
The increasing incidence of IIH, together with the increased
health care utilization in individuals with IIH and particularly
those who have CSF shunts, have important implications for
health care professionals and policy makers.
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